secwatch / observer
8-K filed June 16, 2023, 7:59 PM ET ticker PAHC CIK 0001069899
debt confidence high sentiment neutral materiality 0.60

PHIBRO ANIMAL HEALTH CORP (PAHC): debt financing — Phibro Animal Health enters $50M incremental term loan amendment to credit agreement

PHIBRO ANIMAL HEALTH CORP

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

PHIBRO ANIMAL HEALTH CORP incurred term loan of $50,000,000 with Bank of America, N.A., as administrative agent, the 2023 Incremental Term Loan Lenders and the Consenting Lenders at Base Rate for 2023 Incremental Term Loans ranging from 1.00% to 1.75%; Term SOFR maturing April 22, 2026.

Instrument
term loan
Principal
$50,000,000
Counterparty
Bank of America, N.A., as administrative agent, the 2023 Incremental Term Loan Lenders and the Consenting Lenders
Rate
Base Rate for 2023 Incremental Term Loans ranging from 1.00% to 1.75%; Term SOFR
Maturity
April 22, 2026
Event
incurrence
Exact text from the filing
The Second Amendment amends the Existing Credit Agreement to, among other things, (i) incur incremental term loans in an aggregate principal amount of $50,000,000 (the “2023 Incremental Term Loans”) and (ii) add an additional level to the existing Term Loan and Revolving Credit Facility pricing grid.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.98

PHIBRO ANIMAL HEALTH CORP amended Amended and Restated Credit Agreement, as amended by Amendment No. 2 with Bank of America, N.A. valued at incremental term loans in an aggregate principal amount of $50,000,000 (effective 2023-06-16).

Action
amendment
Agreement
credit facility
Counterparty
Bank of America, N.A.
Value
incremental term loans in an aggregate principal amount of $50,000,000
Effective
2023-06-16
Exact text from the filing
Item 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT. On June 16, 2023 (the "Amendment No. 2 Effective Date"), Phibro Animal Health Corporation (the "Company") entered into Amendment No. 2 (the "Second Amendment") to that certain Amended and Restated Credit Agreement, dated as of April 22, 2021 (as amended, restated, amended and restated, supplemented or otherwise modified as of the date hereof, the "Existing Credit Agreement," and, as further amended by the Second Amendment, the "Credit Agreement"), among the Company, certain of its subsidiaries acting as guarantors, Bank of America, N.A., as administrative agent, the 2023 Incremental Term Loan Lenders and the Consenting Lenders (each as defined in the Second Amendment).
View on SEC.gov

Browse all debt financings →

PHIBRO ANIMAL HEALTH CORP filing history →

Source: SEC EDGAR
accession 0001104659-23-072253
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.